Animol Discovery
Animol: Innovating veterinary drug discovery with a team of experts and a powerful tech platform.
Founded
2019Animol: Innovating veterinary drug discovery with a team of experts and a powerful tech platform.
Animol Discovery, founded by a team of animal health industry experts, focuses on veterinary drug discovery with the mission to deliver innovative and effective treatments for unmet needs in animals. The company utilizes a unique technology platform that integrates genomics analysis, DNA-encoded libraries, and artificial intelligence/machine learning to accelerate the identification and development of proprietary small molecules. Animol Discovery aims to revolutionize animal health by providing safer and more effective pharmaceuticals tailored to specific veterinary needs.
Notable figures in the company include industry veterans with extensive experience in bringing drugs to market. Animol Discovery has garnered attention from key investors in the biotech and veterinary sectors, supporting its pioneering approach. The company has achieved significant milestones in drug development, leveraging its advanced technology platform to create a robust pipeline of veterinary medicines. Overall, Animol Discovery's impact lies in its potential to transform animal healthcare through cutting-edge scientific innovation.
Companies similar to Animol Discovery include AMPLY Discovery, Anagenex, Animal Life Sciences and Animal Biosciences.
Animol Discovery was founded in 2019.
Animol Discovery's headquarters is located in Boston, MA, US.
Animol Discovery's most recent funding round was for $34M (USD) in July 2022.
As of Jul 28, 2022, Animol Discovery has disclosed funding of $40M (USD). Undisclosed round amounts are excluded.
Animol Discovery has 18 employees as of Feb 5, 2024.
Animal Biosciences
